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SUMMARY The purpose of this study was to review
existing principles of oro-facial pain classifications
and to specify design recommendations for a new
system that would reflect recent insights in
biomedical classification systems, terminologies
and ontologies. The study was initiated by a
symposium organised by the International RDC/
TMD Consortium Network in March 2013, to
which the present authors contributed. The
following areas are addressed: problems with
current classification approaches, status of the
ontological basis of pain disorders, insufficient
diagnostic aids and biomarkers for pain disorders,
exploratory nature of current pain terminology
and classification systems, and problems with
prevailing classification methods from an
ontological perspective. Four recommendations for
addressing these problems are as follows: (i)
develop a hypothesis-driven classification structure
built on principles that ensure to our best
understanding an accurate description of the
relations among all entities involved in oro-facial
pain disorders; (ii) take into account the
physiology and phenomenology of oro-facial pain
disorders to adequately represent both domains
including psychosocial entities in a classification
system; (iii) plan at the beginning for field-testing
at strategic development stages; and (iv) consider
how the classification system will be implemented.
Implications in relation to the specific domains of
psychosocial factors and biomarkers for inclusion
into an oro-facial pain classification system are
described in two separate papers.
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Introduction
It is a widely accepted principle that appropriate treat-
ment of what is called ‘oro-facial pain’ requires an
accurate diagnosis. However, biomedical science has
not yet given us the means to determine what would
make such a diagnosis accurate. Because a diagnosis is
an assertion about something, the minimal requirement
for an accurate diagnosis would be a precise determi-
nation of that something. When, for example, we
make a diagnosis of myofascial pain (MFP), what is
that ‘something’ we are talking about? Is it the pain
itself or is it what sometimes is called the underlying
‘disease entity’ which is assumed to cause the pain? If
the latter, what kind of entity is then a ‘disease
entity’, and what is its physical structure? Questions
of this sort are questions about the ontology of pain,
‘ontology’ being the study of the type of entities that
exist in reality, what these entities consist of, and
how they relate to each other. Ontology, ideally,
comes thus prior to terminology, which is the disci-
pline of how to give adequate names to entities, in
the hope that the relevant audiences can easily
understand what the names stand for – that is what
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entities they refer to – and also use the names consis-
tently and univocally.
Unfortunately, the ontology of oro-facial pain disor-
ders – and of pain in general – has not yet been suffi-
ciently established which leads, for instance, to
diagnostic criteria regarding oro-facial pain disorders
which vary considerably across publications. This vari-
ation between diagnostic criteria can cause misalign-
ment of the diagnostic process and lead to inadequate
coverage of the breadth of oro-facial pain disorders (1).
Indeed, the International Headache Society (IHS), the
American Academy of Orofacial Pain (AAOP) and the
International RDC/TMD Consortium Network (Consor-
tium) are all constantly monitoring, if not revising,
their respective classifications due to the evolving
understanding of the respective disorders. The need to
revise classification systems also emerges because our
classification systems are based on the changing foun-
dations of scientific knowledge and understanding.
Differential diagnosis of painful pathologies in the
oro-facial region is a challenge, not only because
patients present with overlapping signs and symp-
toms, but also because they often have the added
challenge of comorbidities. As pain diagnoses mainly
derive from interpretation of the patients’ histories, it
is essential for the clinician to be open-minded and to
search for what is hidden behind patients’ words
when they describe their pain. Therefore, the deriva-
tion of diagnoses from different perspectives warrants
further exploration and development. Insights gleaned
from these can contribute to a classification for oro-fa-
cial pain disorders based on reliable diagnostic criteria.
The challenge regarding oro-facial pain is similar,
although of larger scope, to the one posed by temporo-
mandibular disorders (TMDs). Diagnosis and treatment
of TMDs have suffered for a long time by the lack of
clarity about what should be classified under this term
(2). The most commonly used research classification
system for TMD has been the Research Diagnostic Cri-
teria for Temporomandibular Disorders (RDC/TMD)
(3). Table 1 lists major milestones that have required
substantial investment, collaboration and critique to
develop criteria for the assessment of TMDs. The suc-
cess of this approach for TMDs is, at present, supported
by a number of indicators:
1 the extensive amount of research worldwide on
TMD over the past 20 years that was stimulated by
the publication of the RDC/TMD in 1992;
2 the recursive aspect of the RDC/TMD by which it
facilitated research on itself;
3 early recognition of the RDC/TMD as a model for
all chronic pain disorders (4);
4 successfully addressing criticisms of the RDC/TMD
and subsequent increasing approval of the draft
versions of the DC/TMD at scientific meetings (5–
9);
5 critical analysis by RDC/TMD researchers of the
state of the art in applying the RDC/TMD protocol
(7, 9–11);
6 funding by NIH for the Validation Project (Schiff-
man, PI), to examine the reliability and validity of
the RDC/TMD (12);
7 funding by NIH, because an operationalised classifi-
cation system existed (RDC/TMD), for OPPERA
(Maixner, PI), to identify aetiologic factors involved
in the disorders (13);
8 bridging clinical and research domains via publica-
tion in the newest AAOP Guidelines (14); and
9 the use of the RDC/TMD as the exemplar for the
development of diagnostic criteria for all chronic
pain disorders (15).
The method used to develop diagnostic criteria for
TMD suggests that it may be feasible, utilising similar
efforts, to develop research diagnostic criteria for
other types of oro-facial pain disorders. The above
indicators of progress associated with the development
of the TMD diagnostic taxonomies demonstrate the
widespread adoption and acceptance of the classical
clinical approaches to taxonomy development. How-
ever, these many successes should not obscure the
many questions that continue to surround the classifi-
cation of pain-related disorders.
The science behind the aetiology, pathophysiology
and management of pain disorders, including oro-fa-
cial pain and TMD, is still in an exploratory phase,
and one result is that the terminology used in the
domain remains in permanent flux. More research is
thus required to discover the ontological basis of pain
disorders. That is, we must find out what entities exist
that are to be named, and find out what names cur-
rently in use do, or do not, reflect accurately what
these entities actually are, if anything at all. For
example, is myofascial pain, as the name suggests,
actually related to disorders at the level of muscle and
fascia? Or is it actually only pain felt in muscle that is
centrally generated? The latter has been suspected for
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some time (16), but the available diagnostic systems
did not appear to have the facility to incorporate this
view.
At a similar level of importance to developing
research diagnostic criteria based on sound ontological
principles is research into diagnostic aids and
biomarkers for pain disorders. While diagnostic tests
for pain-related common TMDs exhibit sensitivity and
specificity >090 (17), the link between the test and
underlying pathophysiology of the disorder remains
poorly understood. As a potential bridge between
clinical tests and underlying pathophysiologic pro-
cesses related to the disorder, biomarkers deserve
investigation. Although the presence of certain psy-
chosocial entities has been demonstrated to impact on
the prognosis of pain patients, more research is also
required to assess the effect of psychosocial factors as
moderators or mediators for each of disease progres-
sion and treatment outcome. Moreover, the relation-
ship between moderating or mediating variables and
biomarkers, such as for psychosocial factors or pain
mechanisms, warrants attention. Collectively, these
domains point to areas where the present approach to
classification needs to be carefully evaluated and
revised as additional knowledge accumulates.
The authors of this study were invited to review
the state of the art with respect to formal develop-
ment of diagnostic criteria for oro-facial pain disorders
with the goal to examine the arguments in favour of
or against the development of Research Diagnostic
Criteria for Orofacial Pain (RDC/OFP) and to assess
methods and techniques that most likely would lead
to success. Their findings were presented and dis-
cussed during a symposium organised at the 2013
IADR General Session in Seattle and sponsored by the
International RDC/TMD Consortium Network. The
domains and perspectives represented by the authors
are as follows: oro-facial pain disorders, qualitative
research, behavioural medicine, medical classification
and related statistical methods, and realism-based
ontology. The selection of these specific domains and
perspectives was not intended to be a comprehensive
list of domains relevant for classification; rather, they
represent a particular direction of interest to this
group.
Questions for which answers were sought included
(i) whether traditional and conservative approaches to
medical classification are sufficient or whether they
need to be complemented by recent developments in
the application of Ontological Realism (described
below), (ii) whether psychosocial constructs identified
for TMD are useful for oro-facial pain, (iii) whether
qualitative research methods could provide significant
insights into oro-facial pain which would potentially
affect how we identify entities as well as axes or
dimensions, and (iv) how biomarkers might be incor-
porated into an emerging classification system. In this
study, we outline some major issues associated with
the first question concerning classical approaches to
medical classification. We also offer suggestions for
Table 1. Major milestones and relevance for evolution of the
diagnostic criteria for temporomandibular disorders
Year Milestone Relevance
1992 RDC/TMD published Research community
successful in promoting
critical discussion about
TMD diagnosis through
the use of the
RDC/TMD.
1999 International RDC/TMD
Consortium Network
established
Facilitate better
collaboration among
researchers.
2001 RDC/TMD Validation
Project initiated
Examine the reliability
and validity of RDC/
TMD diagnoses and
Axis II.
2008 Symposium sponsored by
Consortium Network,
held at IADR/Toronto
Researchers not associated
with Validation Project
invited to provide critical
commentary in response
to data-based
presentations by
Validation Project
investigators.
2009 Closed workshop
sponsored by
Consortium Network and
IASP OFP SIG, held at
IADR/Miami
Establish new diagnostic
criteria for TMD and
revise Axis II.
2011 Closed workshop
sponsored by
Consortium Network and
IASP OFP SIG, held at
IADR/San Diego
Expand classification of
TMD to include less
common but clinically
relevant TMDs, evaluate
Axis II and pain
interviews, and create
third axis for
additional measures.
2014 Publication of DC/TMD
and publication of
revised Guidelines for
Orofacial Pain by AAOP
Guidelines incorporated,
for the first time,
research-based
diagnostic criteria.
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avoiding problems that may result from not dealing
with them appropriately, and we provide some overall
recommendations for developing an RDC/OFP. The
ontological literature is, in general, difficult for the
non-specialist to enter; we are not aware of any other
ontology papers with the goal of serving as a tutorial
for the field of pain. We try to provide an introduc-
tion, but this study may be difficult to understand at
times, given that the language is that of ontology and
is necessarily one of precision. The two other papers
in this series (18, 19) address the remaining three
questions and include applications of what we
develop in this paper to the respective domains of
incorporating psychosocial entities and incorporating
biomarker entities into a classification system.
What is Ontological Realism, and how
does it relate to pain disorders?
Ontology is devoted to the study of what entities exist
in reality and how these entities relate to each other.
Applied to pain, an ontological account of pain is thus
one in which researchers try to determine what type
of entity – or types of entities in case the word ‘pain’
would be used in multiple senses – pain is, and what
other types of entities must exist for pain to exist. To
compound the difficulty, the use of ‘pain’ in multiple
senses (or meanings) might not even be recognised.
This situation can be readily illustrated with a histori-
cal medical example: for nearly 50 years, everyone
accepted the assumption that what used to be termed
‘diabetes type 1’ and ‘diabetes type 2’ were two sub-
types of a single disorder, ‘diabetes’. We now know
that there is no ‘diabetes’ at all and that ‘diabetes type
1’ and ‘diabetes type 2’ are two distinct and unrelated
diseases. Therefore, experts no longer formally use
the term ‘diabetes’, yet non-experts and patients still
use that term due to not knowing that diabetes does
not exist. Simultaneously, two other types of entity
exist of which they are unaware.
Ontological Realism has been developed as a specific
philosophical theory that offers a principled methodol-
ogy to (1) analyse domains of interest and (2) build
representational artefacts called ‘ontologies’ that mimic
the structure of reality in accordance with our best sci-
entific understanding (20). Ontological Realism is
based on three axioms. The first axiom is that there is
only one reality and that one reality is objectively the
way it is, that is organised in only one specific way.
The second axiom is that this reality is accessible to
us – we can smell, hear, see, feel, etc. parts of it – and
as a consequence, thanks to the anatomy and physiol-
ogy of our brains, we are able to build cognitive rep-
resentations of that reality and engage in scientific
research.
The third axiom is that these cognitive representa-
tions are not necessarily immediately and fully acces-
sible, and therefore, we need ways of communication
through one or other form of language. Terminolo-
gies, classification systems and ontologies, when prop-
erly designed and corresponding closely to reality,
contribute to better communications linking our rep-
resentations to the underlying reality.
The jaw stretch reflex is an example of the accurate
application of these three axioms: (i) it exists, at least
according to our best scientific understanding; (ii) its
existence has been discovered; and (iii) a name has
been given which adequately encodes what this reflex
is all about. This name also reflects the ontology of
the part of reality in which jaw stretch reflexes exist
because (1) other sorts of stretch reflexes were discov-
ered and (2) the jaw stretch reflex was correctly
recognised as being a specific kind of stretch reflex
related to the jaw.
Adherence to Ontological Realism allows authors of
ontologies, when sufficiently trained, to describe
unambiguously and reproducibly what is generic in
their domain of interest in line with relevant scientific
theories, and to classify discovered entities. Here, ‘en-
tity’ is anything existing such as processes, objects, quali-
ties and dispositions. Most importantly, Ontological
Realism distinguishes between particulars and types.
Particulars are entities that carry identity such as this
paper, the first author of this paper, and the headache
he suffered from while writing this paper. Types are
generic entities which we refer to by using unquali-
fied terms such as ‘paper’, ‘human being’ and ‘pain’
thereby not referring to any specific paper (such as
the one you are reading right now), human being or
pain. Particulars are said to be ‘instances’ of types,
and all particulars that are instances of the same type
form a class.
The method proposed by Ontological Realism
resulted, for example, in the Ontology of General
Medical Science (OGMS). This system provides a col-
lection of carefully defined representational units that
allow biomedical researchers to describe and classify
what they observe in terms of, for instance, disorders,
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diseases, diagnoses and clinical pictures. In addition,
OGMS allows biomedical researchers to identify
where terminology as currently used goes astray (21).
This methodology allowed us, for example, to distin-
guish six types of pain-related phenomena implicitly
present in the IASP definition for ‘pain’ (22). This
methodology also allowed us to provide an ontologi-
cally adequate description of what is called ‘persistent
dento-alveolar pain disorder’ (PDAPD) (23). Persistent
dento-alveolar pain disorder is an ontologically ade-
quate description because it leaves no room for misin-
terpretation as to what each term used in that
description corresponds to in reality. For example, the
pain that patients with PDAPD suffer from is persis-
tent, is constant over time, occurs in the dento-alveo-
lar tissues and, surely, is a pain. The use of the word
disorder at the end of PDAPD is important because it
expresses that when the term is used as a diagnosis
relative to some patient, it does not refer to that
patient’s pain, but to the disorder which forms the
physical basis for that pain.
The ontological basis for describing some portion
of reality – for example the parts of reality involved
in causing, feeling and treating pain – is considered
to be established when scientists have been able to
identify the types of entities that are part of it, and
how instances of these types relate to each other.
Despite tremendous advancement in the field of
pain research in recent years, for example in the
neurophysiology of pain, researchers have not yet
been able to obtain a complete picture of the onto-
logical basis of pain disorders. They also cannot
answer the question of whether the class of ‘pain
disorders’ constitutes a group of entities or is just
the result of a temporary delineation inspired by
lack of deeper insight. Evidence for the latter is as
follows: (i) the unavailability of sufficient diagnostic
aids and biomarkers, (ii) the shifts in terminology,
and (iii) the rather haphazard way in which current
pain classifications are designed, all signs of a
science being in an exploratory rather than explana-
tory phase. Answering the question will be simpler
when pain researchers are offered the methods and
tools to communicate about their findings in ways
which are consistent with a given ontology. In case
no agreement for one specific ontology of choice
can yet be reached, they will need to communicate
about how and in which parts competing ontologies
differ from each other.
Problems with current approaches to
classification
Diagnostic classifications, when adequately designed,
are important for many reasons. Initially, disease-
related classifications aimed to achieve nothing more
than documenting cause of death (epidemiology of
mortality) (24, 25). Diagnoses based on accurate diag-
nostic classifications usually dictate therapeutic
options and indicate a prognosis. Diagnostic labels
offer a form of common language researchers can
communicate in, for instance to classify for research
purposes patients who exhibit certain similarities in
groups that distinguish them from patients classified
in other groups. Moreover, high-quality diagnostic
classifications are the foundation of reliable health
statistics and, in turn, these significantly affect health-
care policies. Accurate and unambiguous classification
of relevant clinical syndromes also ensures proper
reimbursement of healthcare providers for their
services (26).
However, at least three requirements have to be
satisfied to maximise these benefits. The first one is
that the content of a classification should reflect
exactly what exists in reality. If it is the case that dis-
eases truly exist in various types, then an ideal classi-
fication of diseases should contain precisely one
representational unit for each distinct type of disease
that exists. In this manner, each particular disease
from which a patient is suffering can be asserted to
belong to the class formed by all instances of that dis-
ease type. Note that what commonly – nonetheless
wrongly – would be called ‘a definition for disease’ need
not exist for diseases to exist. For example, human
beings clearly existed a long time before there was an
attempt to ‘define’ human being (first axiom of Onto-
logical Realism). What requires definitions are not the
types of entities we discovered to exist through scien-
tific research, but rather the representational units –
such as terms – that we select to denote these types
so that when we use these terms in communication,
our audiences do not understand them differently
than intended.
The second requirement is that the structure of the
classification reflects how the corresponding part of
reality is organised. If, for example, a diagnostic classi-
fication has as its purpose to provide the most effective
treatment, then the classification must be derived from
an ontology which includes representational units for
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the entity types diagnosis, treatment and outcome as well
as for all subtypes thereof. The required level of detail
– in ontological terms the level of granularity – for
these subtypes must be such that any further detail
in, for example, some specific subtype of diagnosis
would not lead to a different outcome for any of the
treatments already associated with that specific sub-
type. If the goal of the diagnostic classification is to
provide the most cost-effective treatment, then the under-
lying ontology needs to contain additional representa-
tional units for the entity cost and its relevant
subtypes up to a level of granularity satisfying the
same requirement explained. This may result in a
diagnostic classification which is differently structured
than the one designed for optimal care. Different does
not, however, mean contradictory: there will be more
detail in certain areas of the first ontology and in
other areas of the second one, but, when both are
correctly designed, the two ontologies could be fused
into one without causing any inconsistencies.
The third requirement relates to what the classifica-
tion has to offer in terms of assisting its users in classi-
fying cases correctly, for instance by using appropriate
terminology, maintaining clear definitions for terms
and providing criteria for class membership. For
example, although an ontologically accurate defini-
tion for the term ‘human being’ would be one stating
that the term refers to entities whose parents are
human beings (it is ontologically accurate as it is
indeed the case today that all and only human beings
have other human beings as parents), it does not help
an alien from outer space to successfully identify
whether one or more of the various life forms an
explorer ship collected are instances of human beings
unless that alien knows already what human beings
are, how they look like, etc.
Clearly, these requirements are currently not met
by diagnostic classifications existing today, and for
sure they are definitely not met in the domain of dis-
eases which manifest themselves through the primary
symptom of pain, for example headache and oro-fa-
cial pain. The current goal of pain classifications is
rather to gain scientific insight into what is the case
in reality: we are still using classifications to discover
rather than represent what is the case, testing them as
models which we know will need to be refined in the
hope that at some point we will get it right. For this
strategy to work, we need to ensure that our classifi-
cations are built so they do not lead to a distorted
view of what we actually believe to exist or that pre-
vent us to see all and only those portions of reality
we want to include for the specific purposes the clas-
sification is designed. Thus, we need instruments to
guide us towards what there is to discover (content)
and instruments to represent relevant discoveries
appropriately through classifications and criteria
(form).
The current headache and TMD classification sys-
tems are, among pain disorders, the most well-devel-
oped at this time. The lack of an ontological basis for
either of these major diagnostic systems is reflected
both in the terminology and the structure which
should be improved to be more precise and unam-
biguous than they have been thus far. For example,
in the ICHD-2, the criteria for chronic tension-type
headache and for migraine without aura overlap,
allowing a person to be diagnosed with both types of
headache for a single headache. This overlap was cor-
rected in ICHD-3, but other overlaps continue such as
in trigeminal neuralgia and short lasting unilateral
neuralgiform headache attacks with autonomic fea-
tures. For TMD, while the common disorders exhibit
criterion validity (17), the uncommon disorders (27)
reflect only face and content validity at this time. The
standard path forward is one of multisite research to
obtain data from enough individuals with these rela-
tively rare conditions that empirical analysis can be
conducted.
Adequate diagnostic aids and biomarkers
for pain disorders are lacking
Diagnosis should not be confused with disease or dis-
order [‘disease’ and ‘disorder’ being terms which in
medical prose are used almost interchangeably (21)]:
diseases are inside the patient, diagnoses are essen-
tially created by the clinician and exist in his under-
standing.
Furthermore, we often use diagnoses that are
defined without knowledge about underlying disease
processes. As we elucidate the exact processes under-
lying the disorder, diagnosis approaches aetiology and
ultimately the ‘true disease’ (28). This is common in
all areas of medicine. Consider migraine that was not
too long ago considered to be a ‘vascular’ headache.
Following investigation, we now appreciate the com-
plexity of the underlying central nervous system
events leading to a migraine, and the vascular
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changes are now understood as only epiphenomena
[e.g. see (29)].
Healthcare providers have become increasingly
dependent on a wide array of laboratory and imag-
ing studies to diagnose and subsequently manage
their patients’ diseases (30). Over the years, research
has enriched medical practice with specific diagnos-
tic biomarkers that aid in diagnosis and enable
assessment of disease control or severity. Unfortu-
nately, these laboratory and imaging studies are lar-
gely unavailable in the field of oro-facial pain (OFP)
(31–33) and headache (HA) (34–37). Ongoing
research [e.g. (38, 39)] may change the situation,
but currently, the predictive value of available
biomarkers in primary OFP or HA diagnosis is very
low (19).
We must, however, appreciate the limitation of
diagnostic tests in any clinical setting but particularly
so in the diagnosis of OFP and HA. In the absence of
adequate biomarkers, the diagnosis of OFP and HA is
based on the clinician’s ability to recognise a particu-
lar combination of signs and symptoms in his or her
patient. Diagnosis, however, remains heavily reliant
on the patient’s ‘story’ as the proxy for the full symp-
tom profile of the phenotype, the way it is related,
and how the clinician interprets these. In many ways,
the diagnosis of OFP and HA is as much an art form
as a science.
Current pain terminology reflects the
exploratory nature of research in pain
disorders
The discipline of giving diseases names is commonly
termed – depending on the principles applied –
‘nomenclature’ or ‘terminology’. Historically, many
diseases have been given the names of the scientist
who initially described them (e.g. Charcot disease) or
of a patient who suffered from it (eponyms; e.g. Lou
Gehrig’s disease). As knowledge accumulates how-
ever, the common consequence is the redefinition of
a disease and eventually its name (e.g. amyotrophic
lateral sclerosis (ALS) as the rename of Charcot dis-
ease and of Lou Gehrig’s disease). In the field of
TMDs, for instance, the recognition and classification
of separate joint and muscle disorders in the late
1980s and early 1990s (3, 40) opened an opportunity
to revise old and irrelevant terminology. Much of this
work has been admirably completed in regard to joint
disorders, but we are still lacking in regard to muscle
pain, particularly chronic masticatory muscle pain.
This is often termed ‘regional myofascial pain disor-
der’ or ‘masticatory muscle myofascial pain’ (MMP)
(41); both terms are still based on an unsupported
premise that the muscle and surrounding fascia are
the origins of the underlying nociception. More
recently, ‘persistent oro-facial muscle pain’ (POMP)
was suggested as an alternative to MMP (42). In this
manner, tension-type headache which was classically
thought to present with pericranial muscle tension
and hence tenderness is now recognised as being able
to present with and without muscle tenderness (43).
Similarly, MMP was described as accompanied by lim-
itation in the jaw’s range of motion, with initial classi-
fications of MMP with and without limitation of
range of motion (3). The absence of empirical data
demonstrating any utility in making that distinction
has now, however, led to it being discarded in the
revised TMD taxonomy (17). Clearly until the aetiol-
ogy of a complaint is determined and until the pheno-
type is clearly identified, medical terminology is by
necessity imprecise (44) in the sense that the names
do not adequately reflect the nature of that what is
named.
Notwithstanding these inherent limitations, clini-
cians, researchers and the international literature usu-
ally adopt strict criteria embedded within universally
accepted names of diseases. This ensures a common
‘medical language’ but establishes a potential fiction
whereby the disorder name reifies the constellation of
stated characteristics as a construct that is widely
accepted but for which a unique physical basis may
not actually exist. The development, however, of a
common medical language, even if flawed, may nev-
ertheless serve a useful stage-specific purpose
whereby data and observation can accrue under the
rubric of the ‘common name’ such that evidence can
support discarding the term. This situation occurred in
the evolution of the RDC/TMD to the DC/TMD (17).
One goal of the present paper was to describe meth-
ods whereby this process can be improved, shortening
the development time of useful classification systems.
That several of the present paper’s authors have pub-
lished research literature and/or monographs that per-
petuate this problem by the presentation of disorders
with ‘accepted’ names is certainly the reason to advo-
cate a more critical approach using better principles
for identifying a’disorder’.
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Contributing further to such reification are society’s
beliefs regarding what constitutes health versus what
constitutes disease. As human diseases affect people of
varied attitudes, expectations and cultures, the very
concept of disease is heterogeneous, yet current taxo-
nomic systems do not generally make that distinction.
For example, the ICHD-2 has included low levels of
headache as a disorder, whereas headache specialists
may regard such low levels of headache as a normal
characteristic of life (e.g. within the range of normal
allostasis) and not a formal disorder. As the basic idea
of disease hinges on deviation from health, the two
are intimately related. Whether people believe them-
selves to be subsequently ‘ill’ varies with class, gender
and ethnic group. These are critical issues that must
be confronted when constructing a disease taxonomy,
regardless of whether using ontological methods or
other approaches. Further elaboration is, however,
beyond the scope of this paper and is, in part,
addressed in Durham et al. (18); moreover, we hope
that others will pursue this issue with regard to oro-
facial pain taxonomic development.
The exploratory nature of pain research
and management is also reflected in pain
disorder classifications
Prevailing design philosophies
Classification, in general, aims to organise a group of
entities into a logical and applicable system that typi-
cally possesses a number of characteristics. A classifi-
cation is based on a plan or ‘schema’ (a formal
description of its structure) that depends on its pur-
pose and that embeds or reflects the view and under-
lying reasoning of its designers (usually a committee)
in terms of how they believe the corresponding
domain to be structured. As a domain can be per-
ceived from many different perspectives, there are
many ways to organise differentiating characteristics
in a classification.
The most prevalent approach for the classification
of pain has been the definition of individual disorders
based on the specific combination of clinical signs and
symptoms. The International Association for the
Study of Pain [IASP] (45), the International Headache
Society [IHS] (43), the International RDC/TMD Con-
sortium Network [Consortium] (3, 17, 27) and the
American Academy of Orofacial Pain [AAOP] (14, 46)
all base their classifications on this approach. To vali-
date that a specific combination of signs and symp-
toms that define the disorder is reliable, advanced
statistical methods are applied (47–51). Many classifi-
cation systems find their initial application in the
research setting (52), for example the RDC/TMD (3).
The RDC/TMD classifies a number of painful and
non-painful disorders of the temporomandibular joint
and muscles of mastication. As discussed previously,
the extensive use of the RDC/TMD in the research
setting has led to a need to simplify, expand and
refine this system (11, 53, 54).
While some classifications are designed towards
one purpose, more advanced classifications may be
versatile enough to cover a number of different pur-
poses. For example, the classification of the IHS is a
hierarchical system that allows increasingly detailed
levels of diagnosis, each level suiting a specific pur-
pose. So as to be a user-friendly and efficient classifi-
cation, the diagnoses (objects) should be in as few
groups as consistent with its purpose. A classification
that aims to record the epidemiology of ‘headache’
may only need to record the major classifications of
these as presented in the major divisions (level 1) of
the IHS classification (43). In contrast, clinical
research on the social impact of migraine headaches
will require more detailed levels of classification
(level 2 or 3). It is interesting to note that there are
‘offshoots’ of these classifications based on specific
characteristics. Thus, ‘chronic facial pain’ (55) or
‘chronic daily headache’ (56) has appeared as ‘tem-
poral’, and ‘indomethacin-responsive headaches’ (57)
as ‘therapeutic’ subclassifications. The former is prob-
ably most useful in epidemiologic and disease burden
studies, while the latter allows a treatment-depen-
dent diagnostic challenge. However, neither approach
offers much advantage in guiding clinical diagnosis
and therapy (55).
Beyond these requirements, different groups may
adopt different grouping philosophies. ‘Lumpers’ will
tend to prefer classifications with major definitions
that include larger patient populations, while ‘split-
ters’ tend to subclassify (52). At the extreme, a ‘split-
ter’s’ philosophy may lead to the conclusion that
there are no diseases, only patients (52)! Of course,
we need both approaches. Regardless of the chosen
‘schema’ and the number of groups, the classification
must include and define (accommodate) all of the
diagnoses in its predefined set of diseases.
© 2015 John Wiley & Sons Ltd
R O L E O F ON T O L OG Y I N O RO - F A C I A L P A I N C L A S S I F I C A T I O N 933
It is common to see that classifications have one or
more categories termed ‘other’ or ‘wastebasket’ diag-
noses (categories). Indeed, we all have patients with
chronic OFP whose diagnosis remains elusive (47, 58,
59). The signs and symptoms do not neatly ‘pigeon
hole’ into established diagnoses. Many of these share
temporal features: pain for most or all of the day,
which is long-standing or chronic (defined here as >6
months) (60). Past attempts at terminology have left
us with diagnoses of ‘diseases’ such as atypical odon-
talgia, atypical facial pain and persistent idiopathic
facial pain; these are inadequate as they tend to lump
a number of underlying diagnostic entities that may
present with similar, but subtly different, clinical phe-
notypes (61, 62). An alternative method whereby
(based on findings) diagnostic hypotheses are tested
enabled us to define novel entities such as ‘neurovas-
cular oro-facial pain’ (47, 63, 64) and ‘painful trau-
matic trigeminal neuropathies’ (65, 66).
Multi-axial systems recognise the biopsychosocial
model of pain with the inherent complexity of the
pain experience and the clear relationship between
onset, treatment response and psychosocial issues
(67–69). For example, the RDC/TMD includes a sepa-
rate axis for the classification of psychosocial dysfunc-
tion/suffering. It would clearly be an advantage to
have integrated classifications of OFP and of HA that
take into account psychosocial factors. These factors
may represent mechanisms that shape the expression
of the phenotype at the diagnostic level (e.g. whether
the threshold for reporting of ‘pain’ in response to pal-
pation is above or below the diagnostic test stimulus
level) or affect comorbidity, prognosis and/or response
to treatment. While the development of multi-axial
systems represents a positive development in disease
conceptualisation via the application of the biopsy-
chosocial model to pain disorders, such systems are not
without problems as discussed in the next section.
Issues with prevailing classification methods from a clinical
perspective
For a number of reasons, current classifications are
not always accurate or adequate. Often, syndromes
overlap in their clinical phenotype. For example, ten-
sion-type headache (TTH) may be extremely difficult
to differentiate from a mild migraine without aura
because of overlap in the appearance of ostensibly
‘diagnostic’ features. Mild nausea and photo- and
phonophobia may also form part of the TTH pheno-
type (43), TTH may be aggravated by exercise (70),
regional muscle tenderness is equally prevalent in
both types of headache (71–73), and even headache
precipitants are identical between migraine and TTH
(74). Interestingly, ‘TTH’ coexisting in migraine suffer-
ers responds to sumatriptan, a migraine-specific drug,
while in non-migraine patients ‘TTH’ does not
respond (75). This suggests that the responsive ‘TTH’
may be a form of mild migraine headache and sup-
ports their phenotypic overlap. Does one headache
type have variable features, between individuals or
perhaps within the same individual across time, or do
these characteristics support two different headache
types? Field-testing of classifications often reveals
novel subtypes of the same diagnosis or new diag-
noses hidden within previous ones. Thus, cluster
headache (CH) was extracted from ‘migraines’, and
subsequently, paroxysmal hemicrania was subclassi-
fied from CH.
In some cases, classifications may be limited in their
scope and clinicians need to use more than one. For
example, the IHS classification is lacking in its
approach to OFP, and to attain reasonable diagnostic
levels, the AAOP and RDC/TMD classifications have
both been needed (47); one recent advance has been
the reconciliation between the clinical (AAOP) and
research (RDC/TMD) systems with the publication of
the DC/TMD (17) that is also incorporated in the
newest edition of the AAOP guidelines (14). Problems
occur even with specifically tailored classifications;
recent validity studies on the RDC/TMD conclude that
the specified clinical tests as independent diagnostic
criteria would be unacceptably susceptible to diagnos-
tic misclassification. Moreover, while the more com-
mon diagnoses had good examiner reliability, some
lack of agreement was clearly present, even when
well-trained examiners perform these procedures
(76).
Finally, a primary challenge for multi-axial systems
is synthesis by the clinician of the many fragments of
information and answering the question: Which axis
(if any) best defines the disease for this individual?
For example, a patient with recurrent headache tem-
porally linked to recurring stressful life events could
be diagnosed according to the type of headache or
could be diagnosed as a stress disorder (where the
headache is just another symptom of the stress). At
present, negotiating this type of direction in a diagno-
© 2015 John Wiley & Sons Ltd
W . C E U S T E R S et al.934
sis is clearly part of the art of medicine; while we in
no way wish to diminish the significance of the phe-
nomenology associated with a clinical phenotype –
that is the role of a patient’s narrative of disease – we
do believe that such circumstances in diagnosis (head-
ache vs. stress as the ‘real’ disorder) could surely be
better reflected in our disease concepts rather than
left to the art or whims of a given provider.
Problems with prevailing classification
methods from an ontological perspective
Even when clinicians and biomedical researchers are
experts in their domain, there is no guarantee that
they are also experts in designing terminologies or
classifications for use in their domain. That the publi-
cation of a (new version of a) classification is based
on consensus is also not a guarantee for quality.
Moreover, quality is usually measured or expressed in
different ways. One aspect of quality is the degree to
which users are able to classify cases in the same
way. Another aspect is whether all cases can be classi-
fied, and an altogether too easy solution to guarantee
full inclusiveness is the introduction of ‘other’ or ‘not
elsewhere classified’ type of classes. Consistency of
classification can be increased by using criteria for
class membership. But then, these criteria need to be
defined in such a way that following the criteria does
not lead to cases being classifiable in more than one
class such that, in the event of a diagnostic classifica-
tion, a specific patient may be diagnosed as having
two disorders at the same time while in reality that
patient has only one disorder.
Quality from an Ontological Realism perspective is
more demanding. It means for classifications that the
definitions for classes must follow certain principles
and that these classes correspond to the ontological
categories that follow the principles of Ontological
Realism. If the classification is designed for the medi-
cal domain, then the classes should be based on
OGMS. The main goal for these additional quality cri-
teria is to ensure not only that ontology-based classifi-
cations can be reliably used by humans, but also that
data sets collected in their terms can be fully inte-
grated. The principles can also be used to demonstrate
how, for example, pain classifications fall short of
good ontological and even terminological design in
many respects. This will be illustrated by listing some
important guidelines and demonstrating how these
are inconsistently adhered to in the International
Classification of Headache Disorders (ICHD-3) (http://
www.ihs-classification.org/_downloads/mixed/Inter-
national-Headache-Classification-III-ICHD-III-2013-Beta.
pdf), specifically in the newly revised Chapter 13; this
is followed by examples from the DC/TMD. These
example taxonomies were chosen because the com-
plexity of headache and facial pain readily lends itself
to exhibiting violations of the ontological principles.
P1: Be explicit whether assertions are about particulars or
types
Assertions should be construed in such a way that the
terms used therein are unambiguous, including
whether types or particulars are intended. The
description in ICHD-3 for’1311 Persistent idiopathic
facial pain (PIFP)’ which reads ‘persistent facial pain with
varying presentations and without clinical neurological defi-
cit’ violates this principle. The term ‘persistent facial
pain’ in the latter is ambiguous as it can be inter-
preted as denoting either a particular or a type. Inter-
preted as denoting some particular, it means that for
a specific patient to have such a pain, that pain – that
is that very same patient’s pain and not some other
patient’s pain – should present itself in various ways,
for instance dull now and throbbing then, to qualify
for being an instance of the type PIFP. Interpreted as
denoting a type, instances would be themselves
invariant, thus some instances being dull, others
throbbing, and so forth.
P2: Be precise about the sort of particulars to be classified
using the classification
The ICHD-3 and its documentation do not present a
coherent view of what might be the most generic type
of which all particulars to be classified should be
instances of. In the preface, we are first told it is disor-
ders and later patients, while some of the definitions
indicate that it is pains. The recently revised Chapter
13 has as title ‘Painful cranial neuropathies and other
facial pains’, thus indicating that it is both pains and
disorders that are classified therein. Inspection of the
hierarchy adds other types to the mix such as palsies
and syndromes. Although certain instances of patients,
pains, palsies, syndromes and disorders are related to
each other, most of these instances cannot be instance
of more than one of these types. It makes therefore
© 2015 John Wiley & Sons Ltd
R O L E O F ON T O L OG Y I N O RO - F A C I A L P A I N C L A S S I F I C A T I O N 935
no sense to classify all these entities in a mono-axial
system.
P3: Particulars that correctly can be classified at a certain
class level and thus are instances of the corresponding type
should also be instance of all the types that correspond with
higher level classes
The newly revised Chapter 13 exhibits several viola-
tions of this principle. It lists, for example, the class
‘1312 Painful Trigeminal Neuropathy’ as a subclass of
‘131. Trigeminal Neuralgia’. While ‘Neuralgia’ is
defined as being pain in the distribution of nerve(s)
and pain as a sensory and emotional experience, a
‘Neuropathy’ is defined as a disturbance of function or
pathological change in a nerve. There is no way that
one can be a special kind of the other as emotional
experiences do not happen in the distribution of a
nerve. Of course, when a neuropathy is painful, there
is an emotional experience involved, that is related to
the neuropathy, but that does not mean that the neu-
ropathy itself is an emotional experience.
P4: Keep knowledge separate from what the knowledge is
about
Several ICHD-3 classes have labels of the form ‘X
attributed to Y’, as in ‘13124 Painful Trigeminal neu-
ropathy attributed to MS plaque’ which is then further
described as ‘Trigeminal neuropathy induced by MS pla-
que’ (note that ‘attributed to’ is not consistent with ‘in-
duced by’, an issue dealt with in P5). ‘Attributed’
means, in this case, that it is somebody’s opinion that
the neuropathy is caused by MS plaque, leaving open
the possibility that the neuropathy is not caused by a
coexisting MS plaque at all. The problem here is that
a feature on the side of the clinician – his or her
believing, probably with some degree of confidence –
is presented as if it were a feature of the neuropathy,
which is of course absurd. Each instance of neuropa-
thy either is or is not induced by MS plaque. It is true
that this sort of classes is pervasive in classification
systems, but they nevertheless rest on a mistake: a
confusion of ontology with epistemology (77).
P5: Class descriptions should be consistent with class labels
There are several instances where the descriptions
contain conflicting (see example in P4), inaccurate or
incomplete (e.g. ‘13124 Painful Trigeminal neuropathy
attributed to MS plaque’ leaves the pain out in the
description) information compared to the class label.
Sometimes it is additional information. It would make
sense to be more consistent in the use of what is
called ‘description’.
P6: Use Aristotelian definitions
Classes should have – in addition to a label and a
description – a definition that provides the necessary
and sufficient conditions for an instance to be a mem-
ber of the corresponding class. These definitions
should be in Aristotelian form, which means that they
are roughly of the form: an X is a Y which is Z, where
Y is the immediate less specific class above X. An
example would be the following: a Painful Post-
Traumatic Trigeminal Neuropathy is a Painful Trigeminal
Neuropathy which occurs after trauma (or is caused by
trauma, whatever the domain experts feel appropri-
ate). Definitions of this form are helpful in avoiding
odd shifts to happen such as between ‘1332. Second-
ary Nervus Intermedius Neuropathy attributed to Herpes
Zoster’ and ‘133 Nervus Intermedius (Facial Nerve) Neu-
ralgia’ which would lead to the rather odd Aristotelian
definition (shortened) of “a . . . Neuropathy . . . is a . . .
Neuralgia . . . which is attributed to Herpes Zoster”’;
no neuropathy can be a pain.
P7: Clinical criteria do not replace Aristotelian definitions
Whereas definitions should describe what the entities
that fall under a class are, clinical criteria help in recog-
nising whether a particular entity might fall under the
class. Such criteria are typically more restrictive than
definitions should be. ‘13111 Classical trigeminal neu-
ralgia, purely paroxysmal’, for example, exhibits the cri-
terion ‘at least three attacks of facial pain fulfilling criteria
B-E’. This criterion should not be interpreted to mean
that patients who had only two such attacks do not
have this form of neuralgia. They might indeed have
the disorder, but the criterion does not allow a clini-
cian to make the – perhaps correct – diagnosis. This
line of thinking applies to all time-related criteria, an
often encountered one being the criterion for chronic
pain as pain that is present for longer than six
months: if a patient does suddenly have a pain for the
first time in his life, it might very well be a chronic
pain, but we have no way to tell at that point in time
© 2015 John Wiley & Sons Ltd
W . C E U S T E R S et al.936
whether that is the case unless we wait six months
(78). If so, it would also be wrong to state that the
patient’s pain became chronic after six months as,
again, it was chronic all the time, but we did not
know. This issue of how chronic pain defined by the
past rather than the prediction of how it will unfold
in the future from this point in time has been criti-
cally addressed elsewhere as well (78), also indicating
the need for more sophisticated approaches to classifi-
cation to capture ‘the potential for’ such ‘change’ over
time: Does this represent a different disorder at the
outset, or does this represent an attribute residing on
a separate axis?
Examples from DC/TMD taxonomy
Examples of non-adherence can even be found in the
DC/TMD and its documentation (whose authorship
includes several of the present authors, hence our
interest in including examples based on the DC/TMD
in addition to the ICHD-3), not the least in the pro-
posed extended taxonomy [see table 4 of (17)].
Almost all labels in the taxonomy are underspecified
with respect to what they stand for (P5): ‘neoplasm’
and ‘subluxation’, for example, are not intended to
include any neoplasm or any subluxation, but only
those involving the TMJ. Worse, where everything
represented in that table is a temporomandibular joint
disorder as made clear by the highest level term (I.),
there is a lower level term (I.2.) which groups what is
called ‘joint disorders’. What is the difference? And if
there is a difference, why assign the same term to dif-
ferent types of entities? The same kind of mistake is
made by introducing ‘I.1.A. – Arthralgia’ as a subtype
of ‘I.1. – pain’: Does ‘arthralgia’ not mean ‘joint
pain’? While this table represents an advancement for
the field of oro-facial pain, as described well in (27),
its limitations were known by the authors simultane-
ous with the recognition that this is a work in pro-
gress.
Using Aristotelian definitions (P6/P7) might have
prevented the misclassification – or, alternatively, the
inadequate definition – of ‘I.5. – Congenital/develop-
mental disorders’ directly under ‘I. – Temporomandi-
bular joint disorders’, rather than under ‘I.2. – Joint
disorders’ (if an argument for the existence of I.2. can
be made at all).
The short version of the diagnostic criteria [table 2 of
(17)] contains, for certain criteria, logical ambiguities
as to what would count for a positive or negative
finding. While the ambiguity is in principle resolved
in the examiners’ protocol (79), a separate level of
concern remains with the criteria as presented for
both research and clinical usage. Specifically, part of
the exam for arthralgia states the following require-
ment: ‘2. Report of familiar pain in the TMJ with at
least one of the following provocation tests: (i) palpa-
tion of the lateral pole or around the lateral pole; OR
(ii) maximum unassisted or assisted opening, right or
left lateral, or protrusive movement(s)’. This leaves
open the question of whether the ‘OR’ involves doing
the test, or the results of the test. From the perspec-
tive of clinical efficiency, it might be sufficient that
one may pick whatever test first and then ignore the
2nd one when the 1st one turns out to be positive;
this would satisfy the criteria as stated. A structured
exam has, as its intent, the systematic gathering of
clinical data such that one has a fixed pool of findings
from which to build deeper understanding of the clin-
ical phenomena (in addition to constructing a diagno-
sis) – perhaps, for example, of value for a differential
diagnosis related to an auxiliary clinical hypothesis.
Consequently, discarding the 2nd test, because the 1st
test was positive and only one finding needs to be
obtained, negates some of the intent and value of a
systematic process. Which goal does the DC/TMD
have for the clinician: efficiency, or systematic evalua-
tion?
Recommendations
In general, our comments indicate that the develop-
ment of a classification system should be hypothesis
driven; relying on only observed data does not shine
the light where the keys might be found again in the
future. Our comments and examples also highlight
the need for ontological rigour in hierarchical classifi-
cation systems to ensure that the relations expressed
among classes correspond to what is the case in real-
ity and are formulated in a way that is logical and
useful. Of course, any classification system, regardless
of the principles underlying its conceptual structure,
must be empirically tested. Yet, a positive outcome of
empirical testing is no guarantee that the principles
described in section 7 are adhered to.
Consequently, our first recommendation for the
development of an oro-facial pain classification system
is to create a template that carefully defines what
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needs to be included, is based on hypotheses about
the disorders and guides the development of a set of
principles for how the classification system will be
structured. We point to the ontologies that have been
developed for such purposes, and we naturally recom-
mend that those ontologies be used, but intermediate
steps in how structure is imposed into a classification
system are always part of the process (15). The arrow
must travel across intermediate space before it reaches
its target, and of course, that space can be dissected
into yet smaller and smaller bits albeit at the cost of
obscuring the goal.
Our second recommendation is that future oro-fa-
cial pain classifications should also contain representa-
tions for various types of psychosocial entities, as we
describe in Durham et al. (18), and for relevant enti-
ties involved in the physiology and phenomenology
of pain disorders. Psychosocial entities are important
for the prognosis of pain disorders and are core com-
ponents of emerging concepts of chronicity (78). Both
quantitative and qualitative researches are of great
value here. While quantitative research has identified
a number of psychosocial entities for incorporation
into an oro-facial pain classification, qualitative
research is useful for verification and explanation
(80). Inclusion of representations of phenomenologi-
cal entities requires still more insight into illness phe-
nomenology. Comprehensive representation of the
full scope of the respective entities requires, at this
time, the incorporation of at least proxies, in the form
of biomarkers, for the physiology associated with the
disorders; here, ‘physiology’ can also refer to that
which underlies what might be observed as the phe-
nomenology – the lived experience – of the entities as
well. We elaborate further in this volume on both
themes in Ceusters et al. (19) and in Durham et al.
(18), respectively. In any case, this second recommen-
dation necessitates the integration of multiple axes
into one hierarchical system which is a challenging
task, yet is indeed motivated following research find-
ings that relate psychological issues with a biomarker
and pain onset [e.g. (81)]. With the two-axis system
of the RDC/TMD and, now, DC/TMD being already
challenged with a 5-axis system specifically targeting
the chronic form of pain disorders (15), the challenge
becomes yet greater. Such ‘multifaceted’ pain classifi-
cations will therefore have to include integrated
criteria for sign/symptom complexes, measures of psy-
chosocial comorbidity, aetiology, consequences and
biomarkers. Their integration will ensure that all mea-
sures are used early in diagnosis, in establishing the
treatment and prognosis, and in assessing outcome
(82). It is here that the ontological approach can con-
tribute a lot through application of the important
ontology-based principles for building classifications as
outlined above.
Our third recommendation is that field-testing dur-
ing strategic stages of development could include
qualitative research, not only of the patients but per-
haps more so of the providers, to explore how a draft
multi-axial classification system built on, for example,
strong ontological principles could be better imple-
mented in the clinical setting.
Our fourth, and final, recommendation is that
requirements for implementation of a classification
system should be considered as part of the overall
development. The RDC/TMD was, to these experi-
enced and perhaps biased authors, appropriate not
only for research but also for clinical use at the outset,
in that approximately 85% of individuals with TMD-
like complaints could be readily classified with the
RDC/TMD (Ohrbach and Dworkin, unpublished data);
we would regard that as excellent, given that those
85% of individuals would be more reliably classified.
Critiques of the RDC/TMD, however, included the fol-
lowing: the system was not comprehensive – did not
classify everyone; too time-consuming; and concern
that population-based parameters could be inappropri-
ate for individual patients. Consequently, the RDC/
TMD was not embraced in most clinical settings.
While it was not intended for use in clinical settings,
it was in fact better than most clinical diagnostic sys-
tems in that it was reliable, based on more data, and
epidemiologically sound. Our fourth recommendation
is aimed at trying to minimise a research-clinic split in
the potential use of any developing taxonomy for
oro-facial pain disorders.
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